Markel Group INC

Market Movers (8-K)

NYSE
Markel Group Inc. presented its 2026 Annual Meeting of Shareholders with a focus on growth, financial conservatism, and operational restructuring.
NYSE
Markel Group Inc. announced strong 2025 financial results and reaffirmed its long-term strategy of compounding capital through disciplined reinvestment, as detailed in its annual Letter to Shareholders.
Better than expected
NYSE
Markel Group Inc. announced significant leadership changes, including new Executive Vice President appointments and executive compensation adjustments, alongside an amendment to its bylaws regarding shareholder special meeting requests.
NYSE
Markel Group Inc. announced its 2025 annual financial results, reporting significant progress with operating revenues up 5% and adjusted operating income increasing 10% for the year.
Better than expected
NYSE
Markel Group Inc. reported increased operating revenues and adjusted operating income for the third quarter and nine months ended September 30, 2025, alongside significant financial reporting re-segmentation.
Better than expected
NYSE
Markel Group Inc. has amended its Articles of Incorporation to remove provisions related to its Series A 6.000% Fixed-Rate Reset Non-Cumulative Preferred Shares, following their full redemption on June 1, 2025.

Quarterly Earnings (10-Q)

NYSE
Markel Group Inc. announced its financial results for the second quarter ended June 30, 2026, showcasing resilience amidst market fluctuations and geopolitical events.
NYSE
Markel Group Inc. reported a net loss for the first quarter of 2026, primarily driven by significant net investment losses, despite stable operating revenues.
Worse than expected
NYSE
Markel Group reports strong operating revenue and adjusted operating income growth in Q3 2025, offset by a significant decline in net investment gains, leading to lower net income.
Worse than expected
NYSE
Markel Group Inc. announced a significant increase in second-quarter net income and comprehensive income, primarily fueled by robust net investment gains, despite a decline in insurance underwriting profit and operating cash flow.
Better than expected
NYSE
Markel Group's Q1 2025 results show a decline in net income due to investment losses, despite growth in insurance operations and Markel Ventures.
Worse than expected
NYSE
Markel Group's Q3 2024 results show a significant increase in net income, primarily due to substantial investment gains.
Better than expected

Annual Reports (10-K)

NYSE
Markel Group Inc. reported robust financial results for 2025, driven by strong underwriting profits and investment income, alongside strategic re-segmentation of its diverse business operations.
Better than expected
NYSE
Markel Group Inc. announces robust 2024 financial results, highlighted by significant operating income and shareholder returns across its insurance, investment, and Markel Ventures segments.
NYSE
Markel Group Inc.'s 10-K filing provides a detailed overview of its registered securities, corporate structure, and regulatory environment.

Insider Trading (Form 4)

NYSE
Brian J. Costanzo, Chief Financial Officer of Markel Group Inc., reported a transaction in 2 shares of common stock on June 30, 2026.
NYSE
Andrew G. Crowley, EVP & Pres., Markel Ventures of Markel Group Inc., reported multiple transactions in common stock on July 15, 2026.
NYSE
Mark Besca, a Director at Markel Group Inc., acquired 80.904 shares of common stock through an employee stock purchase plan.
NYSE
Markel Group Director Morgan E. Housel acquired 65.9218 shares of common stock through the company's Employee Stock Purchase Plan.
NYSE
Diane Leopold, a Director at Markel Group Inc., acquired shares through an employee stock purchase plan.
NYSE
Markel Group Inc. Director Jonathan E. Michael acquired shares through an employee stock purchase plan.

Proxy Statements (Def-14A)

NYSE
Markel Group Inc. has filed a definitive proxy statement with the SEC, indicating upcoming shareholder meetings and voting matters.
NYSE
Markel Group Inc. will hold its 2025 Annual Meeting of Shareholders on May 21, 2025, featuring votes on director elections, executive compensation, auditor ratification, and shareholder proposals.
NYSE
Markel Group Inc. announces its 2024 Annual Meeting of Shareholders to be held on May 22, 2024, detailing voting procedures and proposals.
NYSE
Markel Group Inc. has released its proxy statement for the 2024 Annual Meeting of Shareholders, outlining key proposals including director elections, executive compensation, and a new equity incentive plan.

Institutional Holdings (13F)

NYSE
Markel Group Inc. reported 205 holdings worth $13.1B for the period ended June 30, 2026.
NYSE
Markel Group Inc. disclosed its institutional equity holdings as of March 31, 2026, reporting a total portfolio value of approximately $11.94 billion.
NYSE
Markel Group Inc. filed its Form 13F-HR, revealing an institutional investment portfolio valued at over $12.5 billion across 205 positions as of December 31, 2025.
NYSE
Markel Group Inc. filed its Form 13F-HR, revealing its equity holdings valued at over $12.3 billion as of September 30, 2025.
NYSE
Markel Group Inc. has filed its quarterly Form 13F-HR, revealing an equity portfolio valued at approximately $11.83 billion across 218 distinct holdings as of June 30, 2025.
NYSE
Markel Group Inc. reports its holdings for the quarter ended March 31, 2025, with a total portfolio value of $11.26 billion.

Schedule 13D - Activist Investments

NYSE
Markel Group Inc. has appointed Henrik Bjornstad to the Hagerty, Inc. board following the resignation of Michael R. Heaton.
NYSE
Markel Group Inc. filed an amendment to its Schedule 13D, updating its beneficial ownership in Hagerty, Inc. to 44.9% of Class A Common Stock and 29.9% of total voting power.
NYSE
Markel Group Inc. has filed an Amendment No. 3 to its Schedule 13D, detailing its continued significant beneficial ownership in Hagerty, Inc. and announcing a change in its designated board representative.

Schedule 13G - Passive Investments

NYSE
Vanguard Capital Management reports beneficial ownership of 5.2% of Markel Group Inc.'s common stock as of March 31, 2026.
NYSE
The Vanguard Group reported a 0% beneficial ownership in Markel Group Inc. common stock following an internal realignment, with subsidiaries now reporting separately.